The progression of the species-jumping disease has been unprecedented, including the first-ever U.S. cases of infections in dairy cattle and heightened pandemic risks.
A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...